Article metrics

Download PDFPDF

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: June 2018 to October 2019

AbstractFullPdf
Jun 2018748755271
Jul 201828182875384
Aug 201815341535322
Sep 2018796796207
Oct 2018531531163
Nov 2018461461133
Dec 201830630677
Jan 201934233994
Feb 201933030578
Mar 2019326321122
Apr 2019402373114
May 201928827659
Jun 201922321867
Jul 201928527562
Aug 201922321173
Sep 201918016167
Oct 201921918876
Total1001299262369